DE2547224A1 - Organische verbindungen, ihre verwendung und herstellung - Google Patents
Organische verbindungen, ihre verwendung und herstellungInfo
- Publication number
- DE2547224A1 DE2547224A1 DE19752547224 DE2547224A DE2547224A1 DE 2547224 A1 DE2547224 A1 DE 2547224A1 DE 19752547224 DE19752547224 DE 19752547224 DE 2547224 A DE2547224 A DE 2547224A DE 2547224 A1 DE2547224 A1 DE 2547224A1
- Authority
- DE
- Germany
- Prior art keywords
- coli
- enterotoxin
- labile
- heat
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1467174A CH612994A5 (en) | 1974-11-01 | 1974-11-01 | Process for the preparation of coli enterotoxin |
| CH1645874 | 1974-12-11 | ||
| CH1645974 | 1974-12-11 | ||
| CH604075A CH615196A5 (en) | 1975-05-12 | 1975-05-12 | Purification process for coli enterotoxin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2547224A1 true DE2547224A1 (de) | 1976-05-13 |
Family
ID=27428963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752547224 Ceased DE2547224A1 (de) | 1974-11-01 | 1975-10-22 | Organische verbindungen, ihre verwendung und herstellung |
Country Status (16)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4740585A (en) * | 1984-07-30 | 1988-04-26 | The Board Of Trustees Of The Leland Stanford Junior University | Synthetic vaccine against urinary infections |
| IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA738364B (en) * | 1972-12-04 | 1974-09-25 | Rit Rech Ind Therapeut | Piglet colibacillosis vaccines and process for their preparation |
-
1975
- 1975-10-22 DE DE19752547224 patent/DE2547224A1/de not_active Ceased
- 1975-10-23 DK DK478575A patent/DK478575A/da unknown
- 1975-10-23 FI FI752964A patent/FI752964A/fi not_active Application Discontinuation
- 1975-10-24 NO NO753578A patent/NO753578L/no unknown
- 1975-10-28 NL NL7512590A patent/NL7512590A/xx not_active Application Discontinuation
- 1975-10-28 GB GB44308/75A patent/GB1529871A/en not_active Expired
- 1975-10-29 IE IE2352/75A patent/IE43702B1/en unknown
- 1975-10-30 NZ NZ179108A patent/NZ179108A/xx unknown
- 1975-10-30 DD DD189144A patent/DD124879A5/xx unknown
- 1975-10-30 CA CA238,673A patent/CA1053152A/en not_active Expired
- 1975-10-30 ES ES442242A patent/ES442242A1/es not_active Expired
- 1975-10-30 IL IL48384A patent/IL48384A/xx unknown
- 1975-10-31 FR FR7533471A patent/FR2289206A1/fr active Granted
- 1975-10-31 JP JP50132085A patent/JPS5170810A/ja active Pending
- 1975-11-03 AU AU86282/75A patent/AU511934B2/en not_active Expired
-
1978
- 1978-06-20 DK DK278478A patent/DK278478A/da unknown
- 1978-09-14 FI FI782827A patent/FI782827A/fi not_active Application Discontinuation
-
1981
- 1981-01-23 SE SE8100404A patent/SE8100404L/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU511934B2 (en) | 1980-09-11 |
| SE8100404L (sv) | 1981-01-23 |
| DK478575A (da) | 1976-05-02 |
| FI782827A (fi) | 1978-09-14 |
| NZ179108A (en) | 1978-07-28 |
| IE43702L (en) | 1976-05-01 |
| FR2289206A1 (fr) | 1976-05-28 |
| DD124879A5 (US06265458-20010724-C00033.png) | 1977-03-16 |
| IE43702B1 (en) | 1981-05-06 |
| IL48384A (en) | 1979-05-31 |
| NL7512590A (en) | 1976-05-04 |
| NO753578L (US06265458-20010724-C00033.png) | 1976-05-04 |
| DK278478A (da) | 1978-06-20 |
| FI752964A (US06265458-20010724-C00033.png) | 1976-05-02 |
| FR2289206B1 (US06265458-20010724-C00033.png) | 1978-11-10 |
| JPS5170810A (US06265458-20010724-C00033.png) | 1976-06-18 |
| AU8628275A (en) | 1977-05-12 |
| GB1529871A (en) | 1978-10-25 |
| ES442242A1 (es) | 1977-08-01 |
| IL48384A0 (en) | 1976-03-31 |
| CA1053152A (en) | 1979-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0304786A2 (de) | Intranasale Impfung von Pferden mit inaktivierten Mikroorganismen oder antigenem Material | |
| DE69232969T2 (de) | Methode zur herstellung von gram-negativen bakteriellen vakzinen | |
| DE69432658T2 (de) | Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei) | |
| DE69922990T2 (de) | Herstellungsverfahren von festphasekonjugateimpfstoffen | |
| EP0173241B1 (de) | Vakzine zur Behandlung der Harnwegsinfektionen | |
| DE69731891T2 (de) | Verfahren zur reinigung von gbs-toxin/cm101 | |
| DE60218662T2 (de) | Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine | |
| EP0363835B1 (de) | Verwendung von Zink- oder Eisenhydroxid zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen | |
| DE3024282A1 (de) | Vakzinierende glycopeptid-antigenfraktion mit grosser immunisierungsfaehigkeit, isoliert aus kulturen pathogener keime, verfahren zur isolierung dieser fraktion und diese enthaltende vakzinen | |
| WO1988008032A1 (en) | Receptor from the small rhinovirus receptor group | |
| DE3541044A1 (de) | Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt | |
| DE2547224A1 (de) | Organische verbindungen, ihre verwendung und herstellung | |
| AT364452B (de) | 10rfahren zur reinigung und isolierung von e.colienterotoxin | |
| DE2262427C3 (de) | Immunostimulierendes Mittel | |
| DE2845745C2 (US06265458-20010724-C00033.png) | ||
| EP0491125B1 (de) | Impfstoffe gegen equine Herpesviren und ihre Herstellung | |
| DE2626350C2 (de) | Impfstoff | |
| DE19821859A1 (de) | Darstellung immunogener (Kapsel-)Polysaccharid-Konjugate durch orientierte Kupplung synthetischer T-Zell-Epitope zur Erzeugung von Vakzinen gegen N.meningitidis | |
| AT410172B (de) | Verfahren zur herstellung einer vakzineformulierung | |
| EP0357585B1 (de) | Gegen Pseudomonas aeruginosa-Infektionen wirksame Präparationen sowie Immunglobulin-G-hältige, gegen Bakterium Pseudomonas aeruginosa wirksame Präparationen | |
| DE1966436C3 (de) | Verwendung einer Antigen-Immunserum-Kombination als Impfstoff | |
| CH612994A5 (en) | Process for the preparation of coli enterotoxin | |
| DE19641466A1 (de) | Orale Anwendung eines Immunglobulinpräparates zur Prävention des Hämolytischen Urämischen Syndroms sowie Präparat hierfür | |
| DE905882C (de) | Verfahren zur Gewinnung von Giften und Gegengiften zur Heilbehandlung entsprechender Infektionskrankheiten | |
| AT356823B (de) | Diagnoseverfahren zum nachweis von colien- terotoxin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8131 | Rejection |